title: Liposomal cytarabine given concomitantly with radiotherapy in a patient with leptomeningeal metastasis from breast cancer.
authors.forename: M
authors.initials: M
authors.lastname: Glas
authors.forename: M
authors.initials: M
authors.lastname: Stuplich
authors.forename: H
authors.initials: H
authors.lastname: Tschampa
authors.forename: H
authors.initials: H
authors.lastname: Urbach
authors.forename: K
authors.initials: K
authors.lastname: Rasch
authors.forename: U
authors.initials: U
authors.lastname: Herrlinger
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D001921:Brain / Q000473:pathology; D001943:Breast Neoplasms / Q000473:pathology*; D002277:Carcinoma / Q000188:drug therapy / Q000532:radiotherapy / Q000556:secondary / Q000628:therapy*; D003561:Cytarabine / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008081:Liposomes; D008577:Meningeal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000556:secondary / Q000628:therapy*; D008875:Middle Aged; D018714:Radiotherapy, Adjuvant
chemical_list: D000964:Antimetabolites, Antineoplastic; D008081:Liposomes; D003561:Cytarabine